Abstract:Aims and Objectives: Among skin cancers, malignant skin melanoma is the leading cause of death. Identification of gene markers of malignant skin melanoma associated with survival may provide new clues for prognosis prediction and treatment. This research aimed to screen out potential prognostic predictors and molecular targets for malignant skin melanoma. Introduction: Information regarding gene expression in skin melanoma and patients' clinical traits was obtained from the Gene Expression Omnibus database. Weighted gene co-expression network analysis (WGCNA) was applied to build co-expression modules and investigate the association between the modules and clinical traits. Moreover, functional enrichment analysis was performed for clinically significant co-expression modules. Hub genes of these modules were validated via Gene Expression Profiling Interactive Analysis (GEPIA) and the Human Protein Atlas (http:// www.proteinatlas.org). Methods: First, using WGCNA, 9 co-expression modules were constructed by the top 25% differentially expressed genes (4406 genes) from 77 human melanoma samples. Two co-expression modules (magenta and blue modules) were significantly correlated with survival months (r = 0.27, p = 0.02; r = 0.27, p = 0.02, respectively). The results of functional enrichment analysis demonstrated that the magenta module was mainly enriched in the cell cycle process and the blue module was mainly enriched in the immune response process. Additionally, the GEPIA and Human Protein Atlas results suggested that the hub genes CCNB2, ARHGAP30, and SEMA4D were associated with relapse-free survival and overall survival (all p-values < 0.05) and were differentially expressed in melanoma tumors and normal skin. Results and Conclusion: The results provided the framework of co-expression gene modules of skin melanoma and screened out CCNB2, ARHGAP30, and SEMA4D associated with survival as potential prognostic predictors and molecular targets of treatment.

Integrated Transcriptomic Analysis Reveals the Molecular Mechanism of Meningiomas by Weighted Gene Coexpression Network Analysis

Identification of Glioblastoma Gene Prognosis Modules Based on Weighted Gene Co-Expression Network Analysis

Identification of candidate biomarkers for GBM based on WGCNA

Identification of Key Genes and Pathways in Meningioma by Bioinformatics Analysis.

Weighted Gene Correlation Network Analysis Identifies Microenvironment-Related Genes Signature As Prognostic Candidate for Grade II/III Glioma.

Identify Signature Regulatory Network for Glioblastoma Prognosis by Integrative Mrna and Mirna Co-Expression Analysis.

Mining prognostic marker of glioma based on weighted gene co-expression network analysis

Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients

Comprehensive transcriptomic characterization reveals core genes and module associated with immunological changes via 1619 samples of brain glioma

Predicting Glioblastoma Prognosis Networks Using Weighted Gene Co-Expression Network Analysis on TCGA Data

Four Specific Biomarkers Associated with the Progression of Glioblastoma Multiforme in Older Adults Identified Using Weighted Gene Co-Expression Network Analysis

Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA.

Identification of hub genes related to prognosis in glioma

Integrated Transcriptome Analyses and Experimental Verifications of Mesenchymal-Associated TNFRSF1A As a Diagnostic and Prognostic Biomarker in Gliomas.

Identification of Key Genes Involved in the Recurrence of Glioblastoma Multiforme Using Weighted Gene Co-Expression Network Analysis and Differential Expression Analysis.

Weighted Gene Coexpression Network Analysis Reveals Hub Genes Involved in Cholangiocarcinoma Progression and Prognosis

Identification of Survival‑associated Key Genes and Long Non‑coding RNAs in Glioblastoma Multiforme by Weighted Gene Co‑expression Network Analysis.

Identification of Key Immune and Cell Cycle Modules and Prognostic Genes for Glioma Patients through Transcriptome Analysis

Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis

Identification of key genes and pathways associated with resting mast cells in meningioma

GNG5 is an unfavourable independent prognostic indicator of gliomas